for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Olympus Corp

7733.T

Latest Trade

1,441.00JPY

Change

36.00(+2.56%)

Volume

7,779,500

Today's Range

1,419.00

 - 

1,457.00

52 Week Range

758.75

 - 

1,457.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,405.00
Open
1,429.00
Volume
7,779,500
3M AVG Volume
84.48
Today's High
1,457.00
Today's Low
1,419.00
52 Week High
1,457.00
52 Week Low
758.75
Shares Out (MIL)
1,365.74
Market Cap (MIL)
1,926,136.00
Forward P/E
28.45
Dividend (Yield %)
0.53

Next Event

Dividend For 7733.T - 0.0000 JPY

Latest Developments

More

FDA Recommends Health Care Facilities, Manufacturers Transition To Duodenoscopes With Disposable Components

Olympus Corp - Received Request From Individual Shareholder To Sue Auditor Kpmg Azsa Llc For 88.67 Billion Yen For Past Breach Of Duty

Olympus Corp - Announces 4-1 Stock Split

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Olympus Corp

Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company's segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company's Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products. Its Scientific Solutions Business manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. Its Imaging Business manufactures and sells digital cameras, voice recorders and other products. Its Others Business manufactures and sells biomedical materials, conducts system development and other business activities. Its technologies include optical technologies, electronic imaging technologies, precision technologies and biological based technologies. It has a service network consisting of over 200 sites on approximately six continents.

Industry

Medical Equipment & Supplies

Contact Info

Shinjuku Monolith, 2-3-1, Nishi-Shinjuku

+81.3.33402111

https://www.olympus.co.jp/

Executive Leadership

Hiroyuki Sasa

Executive President, Representative Director

Yasuo Takeuchi

Chief Financial Officer, Executive Vice President, Chairman of Subsidiary, Director

Haruo Ogawa

Chief Technology Officer, Senior Managing Executive Officer, Manager of Technology Development, Director

Kiichi Hirata

Chief Administrative Officer, Managing Executive Officer, Director

Akihiro Taguchi

Senior Managing Executive Officer, Manager of Sales & Marketing, Manager of Surgery Business Unit, Director

Key Stats

2.13 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.7K

2018

0.8K

2019

0.8K

2020(E)

0.8K
EPS (JPY)

2017

57.118

2018

41.710

2019

5.970

2020(E)

49.377
Price To Earnings (TTM)
57.36
Price To Sales (TTM)
2.42
Price To Book (MRQ)
4.46
Price To Cash Flow (TTM)
20.24
Total Debt To Equity (MRQ)
42.22
LT Debt To Equity (MRQ)
28.08
Return on Investment (TTM)
5.23
Return on Equity (TTM)
3.48

Latest News

Sony in $760 million Olympus stake sale after investor Loeb's prodding

Sony Corp <6758.T> is selling its 5% stake in Olympus Corp <7733.T> back to the Japanese medical equipment maker for 80.4 billion yen (£621.3 million), a move that Daniel Loeb's activist hedge fund Third Point LLC had called for.

Japan's Olympus to buy back 5% stake from Sony

Japanese endoscope maker Olympus Corp said on Thursday it will buy back 68.9 million shares, or a 5.03% stake, from Sony Corp.

Olympus whistleblower Woodford wins London pensions lawsuit

The former CEO of Olympus, who blew the whistle on a $1.7 billion (£1.2 billion) accounting scandal at the Japanese medical equipment maker in 2011, has won a London court battle over alleged wrongdoing linked to his 64-million-pound pension.

Japan's Olympus to propose board seat for activist investor ValueAct

Japan's Olympus Corp <7733.T> said it would propose to give top shareholder U.S. hedge fund ValueAct Capital a seat at its board, a rare move in the country where activists are still viewed by companies as asset-strippers to be resisted.

Nikkei ends firmer on positive trade talks; Olympus jumps 8.4 pct

* Olympus surges after two brokerages raise their stock ratings

Nikkei gains on hopes for U.S.-China talks, Olympus leaps 7.6 pct

* Olympus jumps after two brokerages raise their stock ratings

Olympus unit pleads guilty to resolve U.S. duodenoscope probe

An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal...

Activist investor ValueAct has $612 million stake in Japan's Olympus

U.S. hedge fund ValueAct Capital has become a major shareholder in Japanese medical equipment and camera maker Olympus Corp <7733.T> with a 5.04 percent stake that is worth around $612 million at current shares prices.

U.S. hedge fund ValueAct has 5 pct stake in Japan's Olympus

U.S. hedge fund ValueAct Capital has become a major shareholder in Japanese medical equipment and camera maker Olympus Corp with a 5.04 percent stake, a regulatory filing showed on Thursday.

BRIEF-Urogen Pharma Announces Positive Interim Results From Pivotal Phase 3 Olympus Trial Of UGN-101

* UROGEN PHARMA ANNOUNCES POSITIVE INTERIM RESULTS FROM PIVOTAL PHASE 3 OLYMPUS TRIAL OF UGN-101 (MITOGEL™) FOR NON-SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CANCER (UTUC)

BRIEF-Olympus says unit Olympus (Shenzhen) Industrial suspends operation

* Says its unit Olympus (Shenzhen) Industrial Ltd., suspends operation on May 7

BRIEF-Olympus Announces Intention To Acquire Lithotripsy Systems From Cybersonics

* OLYMPUS ANNOUNCES INTENTION TO ACQUIRE LITHOTRIPSY SYSTEMS FROM CYBERSONICS, INC. Source text for Eikon:

BRIEF-U.S. FDA Issues Warning Letters To Duodenoscope Manufacturers, Olympus, Fujifilm And Pentax

* U.S. FDA SAYS ISSUED WARNING LETTERS TO DUODENOSCOPE MANUFACTURERS, OLYMPUS, FUJIFILM, PENTAX FOR FAILING TO COMPLY WITH REQUIREMENTS OF FEDERAL LAW

BRIEF-Hon Hai Precision Industry unit disposes 273,600 shares of Olympus for 1.17 bln yen

* Says co's unit HEROIC LEGEND ENTERPRISES LTD disposes 273,600 shares of Olympus Corporation for 1.17 billion yen in total (4,269.1146 yen per share)

Shell returning workers to Mars, Olympus, Ursa, Ram Powell hubs

Royal Dutch Shell Plc said on Sunday that workers were returning to its Mars, Olympus, Ursa and Ram Powell offshore production hubs in the Gulf of Mexico following the passage of Hurricane Nate.

BRIEF-Olympus to issue 22th series unsecured bonds worth 10 bln yen

* Says it will issue 22th series unsecured corporate bonds worth 10 billion yen with a term of 5 years and coupon rate of 0.22 percent

BRIEF-R&I affirms Olympus's rating at "A-" and says stable outlook-R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-"-R&I

BRIEF-Olympus files appeal to Tokyo District Court

* Says Tokyo District court rejected the partial appeal filed by the company, regarding the lawsuit pending against the six former directors who were involved in serial rigging of accounting activities

REFILE-TABLE-Olympus Corp-2016/17 group results

Olympus Corp CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 748.05 804.58 766.00 366.00 (-7.0...

BRIEF-Olympus to buy U.S. firm Image Stream Medical

* Says U.S.-based firm Image Stream Medical Inc (ISM) will become unit of Olympus Corporation of the Americas, which is wholly owned unit of the co

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up